Posted in Commercial Lilly launches GLP-1 pill, kicking off showdown with Novo Nordisk April 9, 2026 BioPharma Dive After winning the battle for injectable obesity medicines, Lilly hopes Foundayo can help it catch up in the oral market, where Novo has a three-month lead. CommercialMetabolic & GLP-1Read full story